Promoting Compliance to COVID-19 Vaccination in Military Units.
Journal
Military medicine
ISSN: 1930-613X
Titre abrégé: Mil Med
Pays: England
ID NLM: 2984771R
Informations de publication
Date de publication:
29 10 2022
29 10 2022
Historique:
received:
20
02
2021
revised:
10
04
2021
accepted:
27
04
2021
pubmed:
8
5
2021
medline:
2
11
2022
entrez:
7
5
2021
Statut:
ppublish
Résumé
On December 27th, 2020, the Israeli Defense Forces initiated a mass COVID-19 vaccination campaign aiming to vaccinate its personnel. This population upheld specific characteristics in terms of age and sex, lack of significant comorbidities, and a general scarcity of risk factors for sustaining a severe COVID-19 illness. We present the measures taken to increase vaccination compliance, and the vaccination rate that followed these actions. Our secondary goal was to compare between vaccination rates in frontline battalions and highly essential military units (group A) and rear administration and support military units (group B). This was a retrospective review that included 70 military units that were composed of 18,719 individuals of both sexes, mostly free of significant comorbidities. We divided the challenges of maximizing vaccination rates into two main categories: vaccine compliance (including communication and information) and logistical challenges. We compared the vaccination rates in groups A and B using a multivariable linear regression model. A P-value of .05 was considered significant. The mean age in 70 military units was 22.77 ± 1.35 (range 18-50) years, 71.13% males. A total of 726 (3.88%) individuals have been found positive for SARS-CoV-2 between March 1st, 2020 and February 18th, 2021. On February 18th, 2021, 54 days after the vaccination campaign was launched, 15,871 (84.79%) of the study population have been vaccinated by the first dose of Pfizer COVID-19 vaccine, expressing an 88.21% compliance rate (excluding recovered COVID-19 cases who were not prioritized to be vaccinated at this stage). Vaccination compliance in military units from group A was found to be higher when compared to group B (P < .001), leading to a 90.02% of group A population being either previously SARS-CoV-2 positive or COVID-19 vaccinated. A designated army campaign led by a multidisciplinary team could rapidly achieve a high COVID-19 vaccination rate. The information presented can serve organizations worldwide with similar characteristics that plan a mass COVID-19 vaccination campaign.
Sections du résumé
BACKGROUND
On December 27th, 2020, the Israeli Defense Forces initiated a mass COVID-19 vaccination campaign aiming to vaccinate its personnel. This population upheld specific characteristics in terms of age and sex, lack of significant comorbidities, and a general scarcity of risk factors for sustaining a severe COVID-19 illness. We present the measures taken to increase vaccination compliance, and the vaccination rate that followed these actions. Our secondary goal was to compare between vaccination rates in frontline battalions and highly essential military units (group A) and rear administration and support military units (group B).
METHODS
This was a retrospective review that included 70 military units that were composed of 18,719 individuals of both sexes, mostly free of significant comorbidities. We divided the challenges of maximizing vaccination rates into two main categories: vaccine compliance (including communication and information) and logistical challenges. We compared the vaccination rates in groups A and B using a multivariable linear regression model. A P-value of .05 was considered significant.
RESULTS
The mean age in 70 military units was 22.77 ± 1.35 (range 18-50) years, 71.13% males. A total of 726 (3.88%) individuals have been found positive for SARS-CoV-2 between March 1st, 2020 and February 18th, 2021. On February 18th, 2021, 54 days after the vaccination campaign was launched, 15,871 (84.79%) of the study population have been vaccinated by the first dose of Pfizer COVID-19 vaccine, expressing an 88.21% compliance rate (excluding recovered COVID-19 cases who were not prioritized to be vaccinated at this stage). Vaccination compliance in military units from group A was found to be higher when compared to group B (P < .001), leading to a 90.02% of group A population being either previously SARS-CoV-2 positive or COVID-19 vaccinated.
CONCLUSIONS
A designated army campaign led by a multidisciplinary team could rapidly achieve a high COVID-19 vaccination rate. The information presented can serve organizations worldwide with similar characteristics that plan a mass COVID-19 vaccination campaign.
Identifiants
pubmed: 33959759
pii: 6271263
doi: 10.1093/milmed/usab183
pmc: PMC8135994
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1389-e1395Commentaires et corrections
Type : ErratumIn
Informations de copyright
© The Association of Military Surgeons of the United States 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
J Adolesc Health. 2020 Nov;67(5):714-717
pubmed: 33099414
Hum Vaccin Immunother. 2021 Jun 3;17(6):1612-1621
pubmed: 33242386
J Med Virol. 2021 Mar;93(3):1242-1243
pubmed: 33034893
Mil Med. 2020 Sep 18;185(9-10):e1624-e1631
pubmed: 32484225
Vaccine. 2020 Sep 29;38(42):6500-6507
pubmed: 32863069
Lancet Public Health. 2021 Apr;6(4):e195-e196
pubmed: 33556329
Emerg Infect Dis. 2020 Aug;26(8):1666-1670
pubmed: 32324530
JAMA Intern Med. 2020 Sep 1;180(9):1156-1163
pubmed: 32356867
MMWR Morb Mortal Wkly Rep. 2020 Jun 05;69(22):685-688
pubmed: 32497031
Psychol Sci Public Interest. 2017 Dec;18(3):149-207
pubmed: 29611455
World J Virol. 2020 Dec 15;9(5):79-90
pubmed: 33363000
Lancet Public Health. 2021 Apr;6(4):e210-e221
pubmed: 33556325
N Engl J Med. 2021 Feb 18;384(7):e23
pubmed: 33406324
J Med Virol. 2020 Jul;92(7):719-725
pubmed: 32170865
Wellcome Open Res. 2020 Apr 9;5:67
pubmed: 32685698
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
Int J Environ Res Public Health. 2020 Sep 30;17(19):
pubmed: 33007892
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Soc Sci Med. 2021 Jan;268:113370
pubmed: 32980677
Psychiatry Res. 2020 Nov;293:113429
pubmed: 32882598
EClinicalMedicine. 2020 Sep;26:100495
pubmed: 32838242
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
PLoS Med. 2020 Oct 15;17(10):e1003354
pubmed: 33057373
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12283-7
pubmed: 25136134
Mil Med Res. 2021 Jan 25;8(1):8
pubmed: 33487173
Vaccine. 2020 Nov 10;38(48):7587
pubmed: 33121656
JAMA Netw Open. 2020 Oct 1;3(10):e2020981
pubmed: 33001200
J Community Health. 2021 Apr;46(2):270-277
pubmed: 33389421
Arch Dis Child. 2020 Dec;105(12):1192-1196
pubmed: 32868266
Harefuah. 2019 May;158(5):327-331
pubmed: 31104395
Lancet. 2020 Sep 5;396(10252):e22
pubmed: 32861313
Vaccine. 2021 Sep 24;39(40):6004-6012
pubmed: 33160755
Early Hum Dev. 2020 Nov 12;:105256
pubmed: 33221032
Psychiatry Res. 2020 Nov;293:113486
pubmed: 33007682
Am J Prev Med. 2021 Jun;60(6):766-773
pubmed: 33773862